$MCADE presale is now live!

Tilray reports a weak Q1 but gets good news from President Biden

on Oct 9, 2022
Listen to this article
  • Tilray Inc reports weaker-than-expected results for its fiscal first quarter.
  • President Biden pardons thousands convicted of marijuana possession.
  • Tilray shares are currently down about 65% versus their year-to-date high.

Tilray Inc (NASDAQ: TLRY) ended about 20% down on Friday after the cannabis company reported weaker-than-expected results for its fiscal first quarter.

President Biden pardons marijuana convicts

For a long-term investor, though, news from a day earlier is perhaps more noteworthy.

Are you looking for fast-news, hot-tips and market analysis? Sign-up for the Invezz newsletter, today.

On Thursday, President Biden pardoned roughly 6,500 U.S. citizens convicted of “simple marijuana possession”. Reacting to it on CNBC’s “Closing Bell”, Irwin Simon – the Chief Executive of Tilray Inc said:

It’s a really big deal, we’ve all been waiting for this. It is a great step in the right direction. There’s still a lot of wood to chop before we get to full legalisation, but it’s important to know that it’s on the agenda.

As much as 60% of Americans, he added, want authorities to legalise cannabis in the United States.

Classification of marijuana to be reviewed

President Biden also ordered a review of how marijuana is classified. Currently, it’s classified the same as “heroin” on the federal level, which, he noted, “makes no sense”.

There’s a lot of investors that want to see something happen here. Institutions want to be investing in this without the SAFE Banking Act. Demand for cannabis is tremendous.

Versus their year-to-date high, “TLRY” are now down about 65%. It may be a good idea to buy Tilray shares on the weakness considering the Wall Street has an average price target of $4.50 on this stock that represents about a 50% upside from here.

Notable figures in Tilray Q1 financial results

  • Lost $65.8 million versus the year-ago $34.6 million
  • Per-share loss climbed from 8 cents to 13 cents
  • Revenue sunk 9.0% year-on-year to $153.2 million
  • Consensus was 7 cents loss on $155.9 million revenue
  • Cannabis gross margin went up 800 basis points to 51%
  • Ended the quarter with roughly $500 million in cash

Tilray grew its share 8.5% this quarter to remain the top most cannabis company in Canada, as per the earnings press release. CEO Simon added:

We’re well-positioned once cannabis legalises in the United States to come in here and make a major play because of our balance sheet and know how.